Clinical Trials Browser

Phase 1 × Melanoma × Sunitinib × Clear all

NCT01005472 2020-08-03

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Phase 1 Completed

Uveal Melanoma, Melanoma